Evidence map›Paper›PMID 41667136›Full record

ArticleNucleic acids research2026

Structure, function, and applications of two novel phage recombinases from extreme environments.

Emma Tarrant, Isabel G Cormack, Charlotte E Hunter, Olesia Werbowy, Sebastian Dorawa, Lei Wang, Ida Helene Steen, Ruth-Anne Sandaa, Elísabet Eik Guðmundsdóttir, Bernd Ketelsen-Striberny and 4 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Emma TarrantDepartment of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom.
Isabel G CormackDepartment of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom.
Charlotte E HunterDepartment of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom.
Olesia WerbowyDepartment of Microbiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.
Sebastian DorawaLaboratory of Extremophiles Biology, Department of Microbiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.
Lei WangInstitute of Biomedical Genetics, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany.
Ida Helene SteenDepartment of Biological Sciences, Center for Deep Sea Research, University of Bergen, Postboks 7803, N-5020 Bergen, Norway.
Ruth-Anne SandaaDepartment of Biological Sciences, Center for Deep Sea Research, University of Bergen, Postboks 7803, N-5020 Bergen, Norway.
Elísabet Eik GuðmundsdóttirMATIS Ohf, Vínlandsleið 12, 113 Reykjavík, Iceland.
Bernd Ketelsen-StribernyArcticZymes Technologies ASA, Sykehusvegen 23, 9019 Tromsø, Norway.
Anna-Karina KaczorowskaCollection of Plasmids and Microorganisms, Department of Microbiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.
Tadeusz KaczorowskiLaboratory of Extremophiles Biology, Department of Microbiology, Faculty of Biology, University of Gdansk, Wita Stwosza 59, 80-308 Gdansk, Poland.ORCID 0000-0002-2305-2677
Ehmke PohlDepartment of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom.ORCID 0000-0002-9949-4471
Stefanie Freitag-PohlDepartment of Chemistry, Durham University, South Road, Durham DH1 3LE, United Kingdom.

Funding

Engineering and Physical Sciences Research Council EP/S022791/1European Union's Horizon 2020 ResearchInnovation Programme Virus-X project: Viral Metagenomics for Innovation Value 685778Ministry of Education and Science A/SP/453344/202Norway Financial Mechanism through the National Science Center UMO-2019/34/H/NZ2/00584
6 · The paper itself

Abstract

This study describes the identification and characterization of two new extremophilic phage recombinases, UvsXt and UvsXp, discovered through metagenomic analysis within the Virus-X project, and explores their potential applications in biotechnology. DNA recombinases are essential for maintaining genome integrity across all kingdoms of life by facilitating homologous recombination and repairing double-stranded DNA breaks. Their capacity to bind and stabilize single-stranded DNA (ssDNA) has led to wide-ranging applications in molecular biology. UvsXt and UvsXp show homology with known bacterial RecA and viral UvsX recombinases, including conservation of key catalytic residues and DNA-binding motifs. Biochemical assays reveal that both enzymes exhibit superior DNA strand-exchange activity compared to Escherichia coli RecA. High-resolution crystal structures of UvsXt (2.0 Å) and UvsXp (2.6 Å) confirm a conserved RecA-like core fold, with distinct structural variation at the N-terminus responsible for oligomerization. However, in spite of their similarities, we show that neither enzyme is capable to functionally replace RecA in E. coli. Their remarkable thermostability and functionality across diverse chemical environments highlights their robustness for biotechnological use. Notably, UvsXt enhances loop-mediated isothermal amplification of viral RNA by stabilizing ssDNA intermediates. These findings expand the repertoire of thermostable recombinases with potential utility in diagnostic applications.

Indexed as

BacteriophagesRecombinasesViral ProteinsAmino Acid SequenceCrystallography, X-RayDNA-Binding ProteinsDNA, Single-StrandedEscherichia coli ProteinsModels, MolecularMolecular Sequence DataRec A RecombinasesDNA-Binding ProteinsDNA, Single-StrandedEscherichia coli ProteinsrecA protein, E coliRec A RecombinasesRecombinasesViral Proteins

Identifiers

PMID41667136
PMCPMC12890299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.